Buying Mirvac Group (MGR)

by Michael Gable

The following is an extract from our full report this week:

At its 3Q15 operational update, MGR reaffirmed FY15 guidance for operating earnings of 12.2 to 12.3 cents per security and for a full-year distribution of 9.2 to 9.4 cents per security.
MGR remains well placed to overcome the challenges it faces, with the sell down in the stock on the back of these issues presenting an attractive entry point around current levels. In particular, any further weakness in the share price would make the yield more attractive relative to peers, given that:
i. MGR’s 1-year forward yield (5.1%) broadly in line with that for major ASX-listed REITs, notably SGP (5.6%), GPT (5.2%) and Dexus (DXS) (5.5%) and
ii. MGR’s forecast EPS growth for FY16 (+6.3%) outstrips the above peers (SGP: +3.7%, GPT: +3.8% and DXS: +4.7%).
MGR spent nearly 18 months forming an ascending triangle before breaking out of it earlier this year. Having taken only three weeks to rally to a high, it has then taken nearly five times as long to retest that breakout. The timing of this is quite bullish and at current levels MGR has the potential to turn around here and recommence the uptrend. A target would be a retest of February high up near $2.20.



Disclaimer: Michael Gable is an Authorised Representative (No. 376892) and Fairmont Equities is a Corporate Authorised Representative (No. 444397) of Novus Capital Limited (AFS Licence No. 238168). The information contained in this report is general information only and is copy write to Fairmont Equities. Fairmont Equities reserves all intellectual property rights. This report should not be interpreted as one that provides personal financial or investment advice. Any examples presented are for illustration purposes only. Past performance is not a reliable indicator of future performance. No person, persons or organisation should invest monies or take action on the reliance of the material contained in this report, but instead should satisfy themselves independently (whether by expert advice or others) of the appropriateness of any such action. Fairmont Equities, it directors and/or officers accept no responsibility for the accuracy, completeness or timeliness of the information contained in the report.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?